Stent coatings containing hmg-coa reductase inhibitors

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 31/16 (2006.01)

Patent

CA 2464329

Stents with coatings comprising a combination of a restenosis inhibitor comprising an HMG-CoA reductase inhibitor and a carrier. Also provided are methods of coating stents with a combination of an HMG-CoA reductase inhibitor and a carrier. A preferred example of a restenosis inhibitor is cerivastatin. The stent coatings have been shown to release restenosis inhibitors in their active forms.

La présente invention concerne des stents avec des revêtements comprenant une combinaison d'un inhibiteur de resténose comprenant un inhibiteur de réductase HMG-CoA et un porteur. Cette invention concerne aussi des procédés de revêtement de stents avec une combinaison d'inhibiteur de réductase HMG-CoG et d'un porteur. Un exemple préféré d'inhibiteur de resténose est la cérivastatine. On a constaté que ces revêtements de stent libéraient des inhibiteurs de resténose dans leurs formes actives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Stent coatings containing hmg-coa reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stent coatings containing hmg-coa reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent coatings containing hmg-coa reductase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1907996

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.